Clinical Trial Update: Safety, Tolerability and Pharmacokinetic Study of MB12066 in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update reporting safety, tolerability, and pharmacokinetics of MB12066 in healthy volunteers; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome
• Obesity

Drugs mentioned

• MB12066

Snippet

Sponsor: Yungjin Pharm. Co., Ltd. | Conditions: Metabolic Syndrome, Obesity | Phase 1 | Status: COMPLETED